Skip to main content
. 2020 Aug 7;20(6):454–461. doi: 10.1016/j.clbc.2020.08.002

Table 1.

Baseline Patient Characteristics (n = 217)

Parameter Value
Age, y 62.2 ± 13.1
BMI, kg/m2
 Median 23.3
 IQR 23.0-30.4
ASA classification
 I 47 (21.7)
 II 130 (59.9)
 III 40 (18.4)
National screening program diagnosis 55 (25.7)
T stage
 T0 28 (13.5)
 T1 119 (57.5)
 T2 50 (24.2)
 T3 6 (2.9)
 T4 4 (1.9)
 Data missing 10 (4.6)
N stage
 N0 147 (71.0)
 N1 49 (23.7)
 N2 7 (3.4)
 N3 4 (1.9)
 Data missing 10 (4.6)
M stage 0 (0.0)
Neoadjuvant therapy 61 (28.1)
Adjuvant therapy 170 (78.3)
Type of surgery
 BCT 139 (64.1)
 Mastectomy 63 (29.3)
 Other 15 (6.9)
Patients tested for COVID-19 21 (9.7)
Complications
 None 199 (91.7)
 Minor 10 (4.6)
 Major 8 (3.7)

Data presented as mean ± standard deviation or n (%), unless noted otherwise.

Abbreviations: ASA = American Society of Anesthesiologists; BCT = breast conserving therapy; BMI = body mass index; COVID-19 = coronavirus disease 2019; IQR = interquartile range.